| 英文摘要 |
Influenza remains a major global public health concern and seasonal challenge, particularly prevalent during the autumn and winter months. Primarily caused by influenza A and B viruses, it spreads rapidly through droplets, direct contact, and aerosols. Beyond its impact on individual health, influenza is responsible for numerous severe cases and deaths each year, contributing to psychological distress, overwhelming healthcare systems, and imposing significant socioeconomic burdens. Typical symptoms include fever, cough, sore throat, muscle aches, and fatigue, although some patients may develop complications such as pneumonia, cardiovascular issues, or acute respiratory distress syndrome (ARDS). High-risk groups—including infants, older adults, pregnant women, and individuals with chronic illnesses—are especially vulnerable to severe outcomes and increased mortality. Diagnosis relies not only on clinical assessment but also on commonly used tests such as rapid antigen detection and reverse transcription polymerase chain reaction (RT-PCR). Antiviral medications like Oseltamivir and Zanamivir are the mainstays of treatment, supplemented by supportive care. Vaccination remains the most effective preventive measure, complemented by personal protective behaviors such as hand hygiene, mask-wearing, and social distancing. Early intervention for high-risk individuals, appropriate inpatient care for severe cases, judicious use of antibiotics when indicated, and oxygen therapy when necessary can help reduce influenza-related mortality and ease the strain on healthcare services. This article provides a comprehensive overview of influenza from epidemiological, diagnostic, therapeutic, and preventive perspectives to enhance both public and healthcare professionals’understanding and preparedness. |